{"id":"placebo-salve","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin irritation from vehicle or excipients"},{"rate":null,"effect":"Allergic contact dermatitis"}]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo salve","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:51:34.725311+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:51:41.141328+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo salve","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:51:41.446720+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo salves contain inert ingredients with no known pharmacological activity. Their therapeutic benefit arises from the placebo effect—a well-documented phenomenon where patient expectation, conditioning, and the ritual of treatment activate endogenous healing mechanisms, including pain modulation, immune activation, and symptom relief. This is particularly effective for subjective symptoms such as pain, itching, and minor skin irritation.","oneSentence":"A placebo salve produces therapeutic effects primarily through the placebo effect, where the expectation of treatment triggers physiological and psychological responses independent of active pharmacological ingredients.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:01:23.867Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:51:43.481926+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Minor skin conditions and symptoms amenable to placebo response (e.g., mild itching, minor irritation)"}]},"trialDetails":[{"nctId":"NCT06504160","phase":"PHASE1","title":"Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-04-10","conditions":"Atopic Dermatitis","enrollment":86},{"nctId":"NCT07391501","phase":"PHASE4","title":"Nitroglycerin Ointment for Pain Relief After Endoscopic Hemorrhoid Band Ligation","status":"NOT_YET_RECRUITING","sponsor":"Ying Zhu","startDate":"2026-02-01","conditions":"Internal Hemorrhoids, Postoperative Pain After Endoscopic Rubber Band Ligation","enrollment":68},{"nctId":"NCT07158151","phase":"PHASE2","title":"A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Reistone Biopharma Company Limited","startDate":"2025-09-25","conditions":"Atopic Dermatitis of Adults","enrollment":168},{"nctId":"NCT05442190","phase":"PHASE2","title":"Topical SGX302 for Mild-to-Moderate Psoriasis","status":"COMPLETED","sponsor":"Soligenix","startDate":"2022-12-14","conditions":"Psoriasis, Plaque Psoriasis, Psoriasis Vulgaris","enrollment":15},{"nctId":"NCT06400511","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment","status":"TERMINATED","sponsor":"Famy Life Sciences, a Viatris Company","startDate":"2024-04-22","conditions":"Blepharitis","enrollment":477},{"nctId":"NCT07320937","phase":"NA","title":"Effects of Yiqi Fuyuan Paste Formula in Chronic Fatigue Syndrome: A Randomized Double-Blind Controlled Clinical Trial.","status":"ENROLLING_BY_INVITATION","sponsor":"ShuGuang Hospital","startDate":"2025-12-29","conditions":"CFS","enrollment":80},{"nctId":"NCT07318675","phase":"PHASE1","title":"A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.","status":"RECRUITING","sponsor":"Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.","startDate":"2025-12-25","conditions":"Actinic Keratosis (AK)","enrollment":40},{"nctId":"NCT03568318","phase":"PHASE3","title":"A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2018-08-09","conditions":"Atopic Dermatitis","enrollment":1533},{"nctId":"NCT06737406","phase":"NA","title":"Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart","status":"RECRUITING","sponsor":"Mazandaran University of Medical Sciences","startDate":"2025-05-30","conditions":"Common Warts","enrollment":60},{"nctId":"NCT06309355","phase":"PHASE2","title":"Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Hangzhou Yirui Pharmaceutical Technology Co., Ltd","startDate":"2024-06-19","conditions":"Atopic Dermatitis","enrollment":35},{"nctId":"NCT07273656","phase":"PHASE3","title":"Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2025-11-30","conditions":"Keratosis, Actinic Keratoses","enrollment":59},{"nctId":"NCT03363763","phase":"PHASE2","title":"Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex","status":"TERMINATED","sponsor":"Aucta Pharmaceuticals, Inc","startDate":"2017-04-12","conditions":"Angiofibroma of Face, Tuberous Sclerosis","enrollment":24},{"nctId":"NCT07131813","phase":"PHASE4","title":"Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2025-10-10","conditions":"Oral Lichen Planus","enrollment":60},{"nctId":"NCT06744569","phase":"PHASE1","title":"A Phase I Clinical Trial to Evaluate CU-10101 Unguent","status":"ENROLLING_BY_INVITATION","sponsor":"Cutia Therapeutics（Wuxi）Co.,Ltd","startDate":"2024-09-12","conditions":"Atopic Dermatitis","enrollment":64},{"nctId":"NCT04762732","phase":"NA","title":"The Use of iNPWT for Management of ALT Flap Donor Site Wound","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2021-04-08","conditions":"Incisional Negative Pressure Wound Therapy","enrollment":138},{"nctId":"NCT04731259","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety of ATR-04","status":"WITHDRAWN","sponsor":"Azitra Inc.","startDate":"2024-01","conditions":"Epidermal Growth Factor, Papulopustular Rosacea","enrollment":""},{"nctId":"NCT04104178","phase":"PHASE3","title":"Optimal Treatment of MRSA Throat Carriers","status":"COMPLETED","sponsor":"Hvidovre University Hospital","startDate":"2020-05-20","conditions":"MRSA, MRSA Colonization","enrollment":53},{"nctId":"NCT05199077","phase":"PHASE2","title":"A Study of GM-XANTHO in Pressure Ulcer Patients","status":"NOT_YET_RECRUITING","sponsor":"Xantho Biotechnology Co., LTD","startDate":"2026-09-01","conditions":"Pressure Ulcer, Diabetes Mellitus","enrollment":58},{"nctId":"NCT06880276","phase":"PHASE3","title":"Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis","status":"RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-05-16","conditions":"Atopic Dermatitis","enrollment":360},{"nctId":"NCT07137819","phase":"PHASE3","title":"Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis","status":"RECRUITING","sponsor":"Aresus Pharma GmbH","startDate":"2024-09-04","conditions":"Actinic Keratosis of Face and Scalp","enrollment":280},{"nctId":"NCT06075264","phase":"PHASE2","title":"Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)","status":"RECRUITING","sponsor":"Frantz Viral Therapeutics, LLC","startDate":"2023-12-06","conditions":"Vulvar Diseases, HPV Infection, Vulvar HSIL","enrollment":27},{"nctId":"NCT05586776","phase":"PHASE4","title":"Decolonization to Reduce After-Surgery Events of Surgical Site Infection","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-01-17","conditions":"Surgical Site Infection","enrollment":2700},{"nctId":"NCT07073677","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients","status":"NOT_YET_RECRUITING","sponsor":"HK inno.N Corporation","startDate":"2025-07","conditions":"Mild to Moderate Atopic Dermatitis","enrollment":162},{"nctId":"NCT05522816","phase":"PHASE1","title":"KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis","status":"COMPLETED","sponsor":"PharmaEssentia","startDate":"2015-10-27","conditions":"Psoriasis","enrollment":28},{"nctId":"NCT04951206","phase":"PHASE4","title":"Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2022-03-01","conditions":"Vulvar Lichen Sclerosus","enrollment":212},{"nctId":"NCT02094235","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2014-01","conditions":"Atopic Dermatitis","enrollment":62},{"nctId":"NCT01179880","phase":"PHASE1, PHASE2","title":"A Study of E6005 in Japanese Patients With Atopic Dermatitis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-09","conditions":"Atopic Dermatitis","enrollment":40},{"nctId":"NCT06206564","phase":"PHASE2","title":"Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants","status":"RECRUITING","sponsor":"Frantz Viral Therapeutics, LLC","startDate":"2024-01-12","conditions":"Anal High-grade Squamous Intraepithelial Lesion, Anal HSIL, Anal HPV Infection","enrollment":48},{"nctId":"NCT03596073","phase":"PHASE1","title":"Topical Calcipotriene Treatment for Breast Cancer Immunoprevention","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2018-11-07","conditions":"Breast Cancer","enrollment":43},{"nctId":"NCT04329221","phase":"PHASE2","title":"Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2026-01-01","conditions":"Cutaneous Squamous Cell Carcinoma, Actinic Keratoses, Skin Cancer","enrollment":""},{"nctId":"NCT04642287","phase":"PHASE2","title":"Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2026-01","conditions":"Immunotherapy, Cutaneous Squamous Cell Carcinoma, Actinic Keratoses","enrollment":""},{"nctId":"NCT06308393","phase":"PHASE1","title":"Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-03-01","conditions":"Healthy, Psoriatic Subjects","enrollment":98},{"nctId":"NCT05461157","phase":"NA","title":"Preoperative Silicone Ointment and Wound Healing","status":"ENROLLING_BY_INVITATION","sponsor":"Yale University","startDate":"2022-11-14","conditions":"Wound Heal, Scar, Scar, Hypertrophic","enrollment":60},{"nctId":"NCT06363461","phase":"PHASE2","title":"Study of TDM-180935 in Atopic Dermatitis Patients","status":"COMPLETED","sponsor":"Technoderma Medicines Inc.","startDate":"2024-04-13","conditions":"Atopic Dermatitis","enrollment":24},{"nctId":"NCT06013371","phase":"PHASE2","title":"PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2023-07-19","conditions":"Seborrheic Dermatitis, Papulopustular Rosacea","enrollment":32},{"nctId":"NCT06918743","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2025-04","conditions":"Psoriatic Subjects","enrollment":147},{"nctId":"NCT05045469","phase":"PHASE2","title":"Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-08-04","conditions":"Rosacea, Chinese Herbal Medicine","enrollment":24},{"nctId":"NCT06058000","phase":"PHASE2","title":"A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2023-11-13","conditions":"Atopic Dermatitis","enrollment":120},{"nctId":"NCT06850311","phase":"PHASE2, PHASE3","title":"Herbal Ointment in Treating Atopic Dermatitis Topically","status":"RECRUITING","sponsor":"En Chu Kong Hospital","startDate":"2025-03-01","conditions":"Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema)","enrollment":66},{"nctId":"NCT02392130","phase":"PHASE1","title":"A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-03","conditions":"Skin Tissue Diseases, Connective Tissue Diseases","enrollment":40},{"nctId":"NCT02355639","phase":"PHASE1","title":"A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-01","conditions":"Skin and Connective Tissue Diseases","enrollment":16},{"nctId":"NCT05487963","phase":"PHASE1, PHASE2","title":"Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis","status":"COMPLETED","sponsor":"CAGE Bio Inc.","startDate":"2022-11-09","conditions":"Atopic Dermatitis","enrollment":40},{"nctId":"NCT06810050","phase":"PHASE2","title":"Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis","status":"RECRUITING","sponsor":"CAGE Bio Inc.","startDate":"2024-12-18","conditions":"Atopic Dermatitis (AD)","enrollment":180},{"nctId":"NCT06306274","phase":"PHASE2, PHASE3","title":"Topical Tacrolimus for Breast Cancer-related Lymphedema","status":"ENROLLING_BY_INVITATION","sponsor":"Odense University Hospital","startDate":"2024-09-09","conditions":"Lymphedema","enrollment":80},{"nctId":"NCT04593849","phase":"PHASE2","title":"Therapeutic Effects of Traditional Chinese Medicine in Topical Use on Upper Extremities Fracture","status":"COMPLETED","sponsor":"YUAN-CHIEH YEH","startDate":"2020-09-23","conditions":"Bone Fractures, Traditional Chinese Medicine, Chinese Herbal Medicine","enrollment":24},{"nctId":"NCT04299503","phase":"PHASE2","title":"Topical Crisaborole in Patients with Alopecia Areata","status":"WITHDRAWN","sponsor":"Tufts Medical Center","startDate":"2020-03-06","conditions":"Alopecia Areata","enrollment":""},{"nctId":"NCT02432807","phase":"PHASE3","title":"Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis","status":"COMPLETED","sponsor":"Kurobe LLC","startDate":"2015-05","conditions":"Bacterial Conjunctivitis","enrollment":303},{"nctId":"NCT05896215","phase":"PHASE2","title":"OM202JP Clinical Study of KNP2002","status":"COMPLETED","sponsor":"KinoPharma Inc.","startDate":"2023-06-12","conditions":"Common Wart","enrollment":159},{"nctId":"NCT03025282","phase":"PHASE2","title":"Safety and Efficacy of CD10367 in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-11-03","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT05608343","phase":"PHASE3","title":"This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)","status":"COMPLETED","sponsor":"Acrotech Biopharma Inc.","startDate":"2022-10-01","conditions":"Atopic Dermatitis","enrollment":153},{"nctId":"NCT06508372","phase":"NA","title":"Topical Thymoquinone in Psoriasis Vulgaris","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-08-01","conditions":"Psoriasis Vulgaris","enrollment":30},{"nctId":"NCT06026358","phase":"PHASE4","title":"Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands","status":"WITHDRAWN","sponsor":"Medical University of Graz","startDate":"2023-10","conditions":"Actinic Keratoses","enrollment":""},{"nctId":"NCT06396013","phase":"PHASE1","title":"A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.","status":"NOT_YET_RECRUITING","sponsor":"Beijing Hospital of Traditional Chinese Medicine","startDate":"2024-06-01","conditions":"Plaque Psoriasis","enrollment":96},{"nctId":"NCT05231044","phase":"PHASE3","title":"A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp","status":"COMPLETED","sponsor":"PharmaEssentia","startDate":"2021-12-21","conditions":"Actinic Keratosis","enrollment":108},{"nctId":"NCT05491447","phase":"PHASE2","title":"A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis","status":"TERMINATED","sponsor":"BioMimetix JV, LLC","startDate":"2023-01-08","conditions":"Atopic Dermatitis","enrollment":103},{"nctId":"NCT06333600","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss","status":"RECRUITING","sponsor":"Sohag University","startDate":"2023-05-20","conditions":"Dermatology, Female Pattern Baldness","enrollment":45},{"nctId":"NCT04517370","phase":"NA","title":"CO2 Laser Therapy for the Treatment of GSM in Patients With Breast Cancer","status":"COMPLETED","sponsor":"Hadassah Medical Organization","startDate":"2019-02-01","conditions":"Breast Cancer, Genitourinary Syndrome of Menopause","enrollment":36},{"nctId":"NCT05788497","phase":"PHASE3","title":"Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids","status":"TERMINATED","sponsor":"Faes Farma, S.A.","startDate":"2023-03-30","conditions":"Haemorrhoids Without Complication","enrollment":21},{"nctId":"NCT05718921","phase":"PHASE1","title":"A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers","status":"COMPLETED","sponsor":"Hangzhou Yirui Pharmaceutical Technology Co., Ltd","startDate":"2023-04-08","conditions":"Atopic Dermatitis, Psoriasis","enrollment":54},{"nctId":"NCT06170840","phase":"PHASE2","title":"A Study of QY101 Ointment in Subjects With Plaque Psoriasis","status":"UNKNOWN","sponsor":"E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.","startDate":"2023-05-17","conditions":"Psoriasis","enrollment":160},{"nctId":"NCT04037475","phase":"NA","title":"Treatment of Herpes Labialis by Photodynamic Therapy","status":"COMPLETED","sponsor":"University of Nove de Julho","startDate":"2020-01-01","conditions":"Photodynamic Therapy, Herpes Simplex, Labial","enrollment":24},{"nctId":"NCT06133166","phase":"PHASE2","title":"A Study for the Treatment of Dry Eye in Postmenopausal Women","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-09-20","conditions":"Postmenopausal Women With DED","enrollment":240},{"nctId":"NCT05525468","phase":"PHASE1","title":"A Phase 1 Study of TDM-180935 Following Topical Administration in Healthy Male Subjects","status":"COMPLETED","sponsor":"Technoderma Medicines Inc.","startDate":"2023-02-08","conditions":"Healthy","enrollment":58},{"nctId":"NCT01442363","phase":"PHASE2","title":"A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease","status":"TERMINATED","sponsor":"Braintree Laboratories","startDate":"2011-11","conditions":"Perianal Crohn's Disease","enrollment":4},{"nctId":"NCT04717310","phase":"PHASE2, PHASE3","title":"Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis","status":"UNKNOWN","sponsor":"Reistone Biopharma Company Limited","startDate":"2020-12-30","conditions":"Atopic Dermatitis","enrollment":645},{"nctId":"NCT04608448","phase":"EARLY_PHASE1","title":"Topical-RAPA Use in Inflammation Reversal and Re-setting the Epigenetic Clock","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2021-04-28","conditions":"Aging, Epigenetics, Inflammatory Mediators","enrollment":22},{"nctId":"NCT04737304","phase":"PHASE1, PHASE2","title":"A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"BenevolentAI Bio","startDate":"2020-10-14","conditions":"Atopic Dermatitis","enrollment":123},{"nctId":"NCT00944632","phase":"PHASE2","title":"Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-07-15","conditions":"Atopic Dermatitis","enrollment":64},{"nctId":"NCT05838833","phase":"PHASE2","title":"Ointment to Prevent Scar After Thyroidectomy","status":"UNKNOWN","sponsor":"Innovo Therapeutics, Inc.","startDate":"2023-02-14","conditions":"Scar","enrollment":75},{"nctId":"NCT05758259","phase":"PHASE4","title":"The Efficacy and Safety of Topical Vitamin D and Supplementation In Acne Vulgaris The Study of VDR, IL-1β, IL-6, IL-10 and IL-17 Expression","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2023-02-16","conditions":"Acne Vulgaris, Vitamin D","enrollment":105},{"nctId":"NCT00631566","phase":"NA","title":"Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons","status":"COMPLETED","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2007-05","conditions":"HIV Infections, Staphylococcal Infections","enrollment":550},{"nctId":"NCT05729074","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients","status":"UNKNOWN","sponsor":"HK inno.N Corporation","startDate":"2023-02-13","conditions":"Mild to Moderate Atopic Dermatitis","enrollment":80},{"nctId":"NCT02844777","phase":"PHASE2","title":"Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Vidac Pharma","startDate":"2016-07-15","conditions":"Actinic Keratosis","enrollment":93},{"nctId":"NCT05577637","phase":"PHASE1","title":"Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo","status":"COMPLETED","sponsor":"Combined Military Hospital Abbottabad","startDate":"2021-05-01","conditions":"Vitiligo","enrollment":60},{"nctId":"NCT04734405","phase":"PHASE2, PHASE3","title":"A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)","status":"UNKNOWN","sponsor":"ProFem GmbH","startDate":"2019-10-01","conditions":"Recurrent Vulvovaginal Candidiasis","enrollment":432},{"nctId":"NCT05157711","phase":"PHASE3","title":"Clinical Trial of Anusol Ointment for Symptom Relief in Patients With Haemorrhoids","status":"COMPLETED","sponsor":"Church & Dwight Company, Inc.","startDate":"2021-11-25","conditions":"Hemorrhoids","enrollment":66},{"nctId":"NCT04484415","phase":"PHASE3","title":"Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)","status":"UNKNOWN","sponsor":"Asieris MediTech (Hong Kong) Co., Ltd.","startDate":"2020-11-10","conditions":"Cervical Intraepithelial Neoplasia Grade 2/3","enrollment":402},{"nctId":"NCT05040243","phase":"NA","title":"Acupuncture Combined With Yanqing Zhitong Ointment Acupoint Application in Chronic Non-specific Low Back Pain","status":"UNKNOWN","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2021-07-01","conditions":"Non-specific Low Back Pain","enrollment":86},{"nctId":"NCT03682601","phase":"PHASE2","title":"Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment","status":"TERMINATED","sponsor":"GTO Pharmaceutical, LLC","startDate":"2018-08-30","conditions":"Sexual Pain Disorders, Postmenopausal Symptoms, Vulvovaginal Atrophy","enrollment":32},{"nctId":"NCT04753034","phase":"PHASE2","title":"Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis","status":"COMPLETED","sponsor":"Teres Bio, Inc.","startDate":"2021-01-18","conditions":"Atopic Dermatitis","enrollment":63},{"nctId":"NCT04774809","phase":"PHASE2, PHASE3","title":"Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo","status":"TERMINATED","sponsor":"Reistone Biopharma Company Limited","startDate":"2020-01-29","conditions":"Vitiligo","enrollment":75},{"nctId":"NCT04360187","phase":"PHASE3","title":"Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2020-07-27","conditions":"Atopic Dermatitis","enrollment":391},{"nctId":"NCT04918069","phase":"PHASE2","title":"Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN)","status":"COMPLETED","sponsor":"Christian Medical College, Vellore, India","startDate":"2019-10-18","conditions":"Chemotherapy-induced Nausea and Vomiting","enrollment":160},{"nctId":"NCT04083157","phase":"PHASE2, PHASE3","title":"Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2019-08-12","conditions":"Inflammatory Bowel Diseases, Hepatitis B","enrollment":104},{"nctId":"NCT02448381","phase":"PHASE3","title":"FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)","status":"COMPLETED","sponsor":"Soligenix","startDate":"2015-12","conditions":"Cutaneous T-Cell Lymphoma","enrollment":169},{"nctId":"NCT05289726","phase":"PHASE2","title":"Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105","status":"UNKNOWN","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2022-04-18","conditions":"Hand and Foot Skin Reaction, Colorectal Cancer Stage IV","enrollment":152},{"nctId":"NCT02960997","phase":"PHASE2","title":"Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study","status":"COMPLETED","sponsor":"Stanford University","startDate":"2016-05","conditions":"Epidermolysis Bullosa Simplex, Epidermolysis Bullosa Simplex Kobner, Weber-Cockayne Syndrome","enrollment":8},{"nctId":"NCT05174598","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis","status":"COMPLETED","sponsor":"Cadila Pharnmaceuticals","startDate":"2018-10-03","conditions":"Mild to Moderate Plaque Psoriasis","enrollment":278},{"nctId":"NCT05245578","phase":"PHASE1","title":"Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects","status":"COMPLETED","sponsor":"PharmaEssentia","startDate":"2021-11-16","conditions":"Healthy Volunteer","enrollment":20},{"nctId":"NCT02223520","phase":"NA","title":"Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2014-11","conditions":"Staph Aureus Colonization, Staph Aureus Infection","enrollment":307},{"nctId":"NCT04764552","phase":"NA","title":"Yeahhh Baby! Ointment on Hip and/or Knee Pain in Men and Women","status":"COMPLETED","sponsor":"University of Memphis","startDate":"2021-02-09","conditions":"Joint Pain","enrollment":20},{"nctId":"NCT02068352","phase":"PHASE2","title":"A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2014-06-20","conditions":"Atopic Dermatitis","enrollment":121},{"nctId":"NCT02068599","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2014-04-14","conditions":"Osteoarthritis of the Knee","enrollment":389},{"nctId":"NCT02215941","phase":"PHASE1","title":"Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2014-08","conditions":"Pharmacokinetics","enrollment":45},{"nctId":"NCT02365636","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2015-02-26","conditions":"Postherpetic Neuralgia","enrollment":300},{"nctId":"NCT04049552","phase":"EARLY_PHASE1","title":"RAPA-Keloid Study of Keloid Regression","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2020-01-24","conditions":"Keloid","enrollment":4},{"nctId":"NCT04273997","phase":"PHASE2","title":"Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds","status":"UNKNOWN","sponsor":"S.L.A. Pharma AG","startDate":"2021-10-01","conditions":"Pilonidal Sinus","enrollment":80},{"nctId":"NCT05036174","phase":"NA","title":"Diphenhydramine Ointment for Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology","startDate":"2021-09","conditions":"Osteoarthritis","enrollment":30},{"nctId":"NCT05032248","phase":"NA","title":"Uses of Tacrolimus in Behcet Disease","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-04-01","conditions":"Oral Ulcer, Behcet Syndrome","enrollment":40},{"nctId":"NCT03868098","phase":"PHASE4","title":"Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Innovaderm Research Inc.","startDate":"2019-05-21","conditions":"Dermatitis, Atopic","enrollment":31}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo salve","genericName":"Placebo salve","companyName":"Medical University of Graz","companyId":"medical-university-of-graz","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo salve produces therapeutic effects primarily through the placebo effect, where the expectation of treatment triggers physiological and psychological responses independent of active pharmacological ingredients. Used for Minor skin conditions and symptoms amenable to placebo response (e.g., mild itching, minor irritation).","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:51:43.481926+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}